REDOX LIMITED (RDX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RDX

RDX - REDOX LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.35
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.41

20 Feb
2025

-0.900

OPEN

$3.66

-20.88%

HIGH

$3.66

2,184,548

LOW

$3.28

TARGET
$3.517

+0.13 change from previous day

 3.1% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AIM . ANN . ASB . CUP . DGL . KPG . QHL . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
RDX: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 17.2 16.4 xxx
DPS (cps) xxx 12.5 11.3 xxx
EPS Growth xxx 11.9% - 4.5% xxx
DPS Growth xxx N/A - 9.6% xxx
PE Ratio xxx N/A 19.7 xxx
Dividend Yield xxx N/A 3.5% xxx
Div Pay Ratio(%) xxx 72.7% 68.8% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.86

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 01/03 - ex-div 6c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 20202021202220232024
EPS Basic xxxxxxxxxxxx17.2
DPS All xxxxxxxxxxxx12.5
Sales/Revenue xxxxxxxxxxxx1,137.3 M
Book Value Per Share xxxxxxxxxxxx101.2
Net Operating Cash Flow xxxxxxxxxxxx115.9 M
Net Profit Margin xxxxxxxxxxxx7.93 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20202021202220232024
Return on Capital Employed xxxxxxxxxxxx23.55 %
Return on Invested Capital xxxxxxxxxxxx18.83 %
Return on Assets xxxxxxxxxxxx14.07 %
Return on Equity xxxxxxxxxxxx23.55 %
Return on Total Capital xxxxxxxxxxxx24.41 %
Free Cash Flow ex dividends xxxxxxxxxxxx80.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20202021202220232024
Short-Term Debt xxxxxxxxxxxx20 M
Long Term Debt xxxxxxxxxxxx27 M
Total Debt xxxxxxxxxxxx47 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx179 M
Price To Book Value xxxxxxxxxxxx3.02

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20202021202220232024
Capex xxxxxxxxxxxx3.8 M
Capex % of Sales xxxxxxxxxxxx0.34 %
Cost of Goods Sold xxxxxxxxxxxx871 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx140 M
Research & Development xxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

21/02/2025

1

Overweight

$3.90

14.37%

First half net profit from Redox missed Morgan Stanley's estimate, amid higher operating expenditure. The top line was in line with expectations with the broker noting strong volumes into the second half.

The cost rebasing for FY25 should be a one-off and the broker believes there is scope to sustain the 21.6% gross margin, particularly as product mix has normalised.

Overweight. Target is reduced to $3.90 from $4.50. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY25 dividend of 10.10 cents and EPS of 15.50 cents.
Morgan Stanley forecasts a full year FY26 dividend of 11.00 cents and EPS of 16.90 cents.

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

RDX STOCK CHART

FNArena News on RDX

1
FNArena Corporate Results Monitor – 22-02-2025

2:00 PM - Australia
2
Rudi’s View: Best Ideas & Conviction Calls

Feb 20 2025 - Rudi's View
3
Rudi’s View: AGL Energy, Bega Cheese, BRG, Harvey Norman, Imdex & Superloop

Feb 06 2025 - Rudi's View
4
Rudi’s View: Cochlear, Guzman y Gomez, SiteMinder, Wesfarmers & Xero

Jan 30 2025 - Rudi's View
5
Rudi’s View: Feb Season’s Best Buys & Key Picks

Jan 23 2025 - Rudi's View

Latest Commercial Services & Supplies News

1
Pro Medicus’ Valuation Predicament

Feb 19 2025 - Australia
2
Amcor Confident In Berry On Top

Feb 07 2025 - Australia
3
DeepSeek Fuels AI Technology Advances

Feb 06 2025 - Feature Stories
4
DeepSeek & More AI Excitement For 2025

Jan 28 2025 - Feature Stories
5
Xero: The Pause That Refreshes

Jan 23 2025 - Technicals
6
Looking For Durable, Needle-Moving Growth In AI

Jan 13 2025 - International
7
In Brief: Dicker Data, Light & Wonder, Codan

Dec 20 2024 - Weekly Reports
8
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
9
Alliance Aviation Cleared For Dividend Takeoff

Dec 16 2024 - Small Caps
10
The 2024 Gen.Ai Xmas Special, Incl 2025 Outlook

Dec 12 2024 - Australia